162 related articles for article (PubMed ID: 30199861)
1. Tretinoin Loaded Nanoemulsion for Acne Vulgaris: Fabrication, Physicochemical and Clinical Efficacy Assessments.
Sabouri M; Samadi A; Ahmad Nasrollahi S; Farboud ES; Mirrahimi B; Hassanzadeh H; Nassiri Kashani M; Dinarvand R; Firooz A
Skin Pharmacol Physiol; 2018; 31(6):316-323. PubMed ID: 30199861
[TBL] [Abstract][Full Text] [Related]
2. Efficacy assessments of tretinoin-loaded nano lipid carriers in acne vulgaris: a double blind, split-face randomized clinical study.
Samadi A; Sartipi Z; Ahmad Nasrollahi S; Sheikholeslami B; Nassiri Kashani M; Rouini MR; Dinarvand R; Firooz A
Arch Dermatol Res; 2022 Aug; 314(6):553-561. PubMed ID: 34146120
[TBL] [Abstract][Full Text] [Related]
3. Safety Assessment of Tretinoin Loaded Nano Emulsion and Nanostructured Lipid Carriers: A Non-invasive Trial on Human Volunteers.
Nasrollahi SA; Hassanzade H; Moradi A; Sabouri M; Samadi A; Kashani MN; Firooz A
Curr Drug Deliv; 2017; 14(4):575-580. PubMed ID: 27174174
[TBL] [Abstract][Full Text] [Related]
4. Tailoring of Retinyl Palmitate-Based Ethosomal Hydrogel as a Novel Nanoplatform for Acne Vulgaris Management: Fabrication, Optimization, and Clinical Evaluation Employing a Split-Face Comparative Study.
Salem HF; Kharshoum RM; Awad SM; Ahmed Mostafa M; Abou-Taleb HA
Int J Nanomedicine; 2021; 16():4251-4276. PubMed ID: 34211271
[TBL] [Abstract][Full Text] [Related]
5. Enhanced skin targeting of retinoic acid spanlastics:
Shamma RN; Sayed S; Sabry NA; El-Samanoudy SI
J Liposome Res; 2019 Sep; 29(3):283-290. PubMed ID: 30501429
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial.
Prasad S; Mukhopadhyay A; Kubavat A; Kelkar A; Modi A; Swarnkar B; Bajaj B; Vedamurthy M; Sheikh S; Mittal R
Indian J Dermatol Venereol Leprol; 2012; 78(4):459-67. PubMed ID: 22772617
[TBL] [Abstract][Full Text] [Related]
7. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin.
Ridolfi DM; Marcato PD; Justo GZ; Cordi L; Machado D; Durán N
Colloids Surf B Biointerfaces; 2012 May; 93():36-40. PubMed ID: 22244299
[TBL] [Abstract][Full Text] [Related]
8. Topical liposomal gel of tretinoin for the treatment of acne: research and clinical implications.
Patel VB; Misra A; Marfatia YS
Pharm Dev Technol; 2000; 5(4):455-64. PubMed ID: 11109245
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous absorption and antibacterial activities of lipid nanocarriers loaded with dual drugs for acne treatment.
Lin CH; Fang YP; Al-Suwayeh SA; Yang SY; Fang JY
Biol Pharm Bull; 2013; 36(2):276-86. PubMed ID: 23370356
[TBL] [Abstract][Full Text] [Related]
10. Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.
Piérard-Franchimont C; Henry F; Fraiture AL; Fumal I; Piérard GE
Dermatology; 1999; 198(2):218-22. PubMed ID: 10325486
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris.
Kircik LH; Dahl A; Yatskayer M; Raab S; Oresajo C
J Drugs Dermatol; 2012 Jun; 11(6):737-40. PubMed ID: 22648221
[TBL] [Abstract][Full Text] [Related]
12. Topical Nano-emulgel for Skin Disorders: Formulation Approach and Characterization.
Ahmad J; Gautam A; Komath S; Bano M; Garg A; Jain K
Recent Pat Antiinfect Drug Discov; 2019; 14(1):36-48. PubMed ID: 30488798
[TBL] [Abstract][Full Text] [Related]
13. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris.
Nyirady J; Grossman RM; Nighland M; Berger RS; Jorizzo JL; Kim YH; Martin AG; Pandya AG; Schulz KK; Strauss JS
J Dermatolog Treat; 2001 Sep; 12(3):149-57. PubMed ID: 12243706
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
Richter JR; Förström LR; Kiistala UO; Jung EG
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
[TBL] [Abstract][Full Text] [Related]
15. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study.
Jarratt MT; Brundage T
J Drugs Dermatol; 2012 Mar; 11(3):318-26. PubMed ID: 22395582
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
18. Formulation of tretinoin-loaded topical proniosomes for treatment of acne: in-vitro characterization, skin irritation test and comparative clinical study.
Rahman SA; Abdelmalak NS; Badawi A; Elbayoumy T; Sabry N; El Ramly A
Drug Deliv; 2015; 22(6):731-9. PubMed ID: 24670094
[TBL] [Abstract][Full Text] [Related]
19. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.
Cunliffe WJ; Danby FW; Dunlap F; Gold MH; Gratton D; Greenspan A
Eur J Dermatol; 2002; 12(4):350-4. PubMed ID: 12095880
[TBL] [Abstract][Full Text] [Related]
20. Topical Vehicle Formulations in the Treatment of Acne.
Hoffman LK; Bhatia N; Zeichner J; Kircik LH
J Drugs Dermatol; 2018 Jun; 17(6):s6-s10. PubMed ID: 29879262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
